A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

Clinical trial NCT03742102 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03742102
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Neoplasms

Start date: 2018-12-21
Primary completion: 2024-11-29
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.